Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease ; volume:15 ; number:1 ; day:15 ; month:2 ; year:2018 ; pages:1-11 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (15.2.2018), 1-11, 12.2018
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Casali, Brad T.
- Beteiligte Personen und Organisationen
-
Reed-Geaghan, Erin G.
Landreth, Gary E.
SpringerLink (Online service)
- DOI
-
10.1186/s12974-018-1091-y
- URN
-
urn:nbn:de:1111-201804082548
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Casali, Brad T.
- Reed-Geaghan, Erin G.
- Landreth, Gary E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease